尤瑞克林治疗脑血栓患者的临床疗效探讨

Clinical Curative Effect Observation on Urinarykallid in Treatment of Patients with Cerebral Infaction

目的探讨尤瑞克林对脑血栓患者临床治疗的疗效。方法整群选取2013年9月—2015年6月来该院就诊的142例脑血栓患者,随机分为两组,对照组71例给予脑血栓常规治疗,观察组71例在此基础上加用尤瑞克林治疗,比较两组临床疗效。结果观察组神经功能缺损评分降低程度明显多于对照组,同时观察组治疗总有效率为87.33%,明显优于对照组74.65%的总有效率,差异有统计学意义(P<0.05)。结论常规治疗基础上加用尤瑞克林治疗脑血栓效果明显,其不仅能有效缩小脑梗死体积、改善侧枝循环,还能降低患者神经功能缺损评分,并且无明显不良反应。

Objective To observe the clinical treatment curative effect of urinarykallid in treatment of patients with cerebral infaction. Methods 142 cases of patients with cerebral infaction treated in our hospital from September 2013 to June 2015 were randomly divided into two groups with 71 cases in each, the control group were treated with conventional method, the observation group were treated with additional urinarykallid on the basis of the control group, the clinical curative effect of the two groups was compared. Results The decreased degree of neural function defect scale in the observation group was obviously higher than that in the control group, at the same time, the total treatment effective rate in the observation group was obviously better than that in the control group（87.33% vs 74.65%）, the differences were statistically significant（P〈0.05）. Conclusion The effect of additional urinarykallid treatment for cerebral infaction on the basis of conventional treatment is obvious, which can not only effectively decrease cerebral infarct volume, improve the collateral circulation, but also decrease the patient＇s neural function defect scale without obvious adverse reactions.